IVS-3001

N/A

Report date: 2023/08/04 15:29:08

Base Information

Drug NameIVS-3001

Drug Alias NameIVS-3001

ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy > Chimeric antigen receptor T cell therapy

Mechanisms of ActionHLA class I histocompatibility antigen, alpha chain G inhibitors

TargetsHLA class I histocompatibility antigen, alpha chain G

Therapy Area/IndicationsSolid tumours

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPhase 2 Clinical

Highest Status in ChinaN/A

Originator CompaniesInvectys

China Registration ClassN/A

Develop Information

Active CompaniesInvectys

Inactive CompaniesN/A

Active IndicationsSolid tumours

Inactive IndicationsN/A

Other Information

ATC CodeN/A